Report Categories
View AllRecent Articles
View All
RIGL Rigel Pharmaceuticals posts Q4 2025 EPS below analyst estimates with shares slipping 11 in todays trading
XSLL Xsolla rolls out new developer monetization tools to support longterm revenue growth
Limbach Holdings LMB Stock Pricing Evaluation Q4 2025 Profit Disappoints
GNRC Generac Holdlings posts 328 percent Q1 2026 EPS beat shares see modest gain today
CDZIP Cadiz posts wider than expected Q3 2025 loss shares remain flat following quarterly earnings release
International Business Machines IBM Valuation Gap Assessment and Investment Thesis Following Recent Share Price Weakness
What CapFed CFFN does that keeps customers coming back Smart Money Exits 20260508
AUPH Aurinia beats Q4 2025 EPS estimates by 176 percent yet shares dip 1 percent in todays session